MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,857,790 | -56.1% | 42,649 | -63.6% | 0.01% | -52.4% |
Q2 2023 | $4,232,666 | -16.6% | 117,151 | -14.2% | 0.02% | -25.0% |
Q1 2023 | $5,074,549 | +66.7% | 136,486 | +557.7% | 0.03% | +86.7% |
Q4 2021 | $3,044,000 | +299.5% | 20,751 | +366.5% | 0.02% | +275.0% |
Q1 2021 | $762,000 | +15.1% | 4,448 | +47.6% | 0.00% | 0.0% |
Q4 2020 | $662,000 | +1041.4% | 3,013 | -81.1% | 0.00% | – |
Q2 2017 | $58,000 | -29.3% | 15,900 | +0.6% | 0.00% | -100.0% |
Q1 2017 | $82,000 | – | 15,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |